Literature DB >> 25159208

Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Xiaoman Li1, Xiaowu Gu1, Timothy M Boyce1, Min Zheng1, Alaina M Reagan1, Hui Qi1, Nawajes Mandal1, Alex W Cohen1, Michelle C Callegan1, Daniel J J Carr2, Michael H Elliott1.   

Abstract

PURPOSE: Caveolin-1 (Cav-1), the signature protein of caveolae, modulates inflammatory responses, and innate immunity. However, Cav-1's role in retinal inflammation has not been rigorously tested. In this study, we examined the effect of Cav-1 ablation on the sensitivity of the retina to inflammation.
METHODS: Cav-1 knockout (KO) mice were challenged by intravitreal injection of lipopolysaccharide (LPS) and inflammatory cell recruitment was assessed by flow cytometry and immunohistochemistry. Leukostasis was assessed in retinal flatmounts after perfusion with FITC-labeled Concanavalin A (FITC-ConA). Chemoattractants were measured by multiplex immunoassays. Blood-retinal barrier (BRB) breakdown was assessed quantitatively by a FITC-dextran permeability assay. The ratio of extravascular to total immune cells was determined by CD45 immunohistochemistry of retinal flatmounts.
RESULTS: Inflammatory challenge resulted in significant blunting of proinflammatory cytokine (monocyte chemoattractant protein-1 [MCP-1/CCL2], CXCL1/KC, IL-6, and IL-1β) responses as well as reduced inflammatory BRB breakdown in Cav-1 KO retinas. Paradoxically, Cav-1 deficiency resulted in significantly increased recruitment of immune cells compared with controls as well as increased leukostasis. A similar ratio of extravascular/total leukocytes were found in Cav-1 KO and wild-type (WT) retinas suggesting that Cav-1 deficient leukocytes were as competent to extravasate as those from WT mice. We found increased levels of circulating immune cells in naïve (not challenged with LPS) Cav-1 KO mice compared with controls.
CONCLUSIONS: Caveolin-1 paradoxically modulates inflammatory signaling and leukocyte infiltration through distinct mechanisms. We hypothesize that Cav-1 expression may enhance inflammatory signaling while at the same time supporting the physical properties of the BRB. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  blood–retinal barrier; caveolin; cytokines; inflammation

Mesh:

Substances:

Year:  2014        PMID: 25159208      PMCID: PMC4183075          DOI: 10.1167/iovs.14-14613

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  75 in total

1.  Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains.

Authors:  A W Stitt; G A Burke; F Chen; C B McMullen; H Vlassara
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  A comparison of caveolae and caveolin-1 to folate receptor alpha in retina and retinal pigment epithelium.

Authors:  C C Bridges; A El-Sherbeny; P Roon; M S Ola; R Kekuda; V Ganapathy; R S Camero; P L Cameron; S B Smith
Journal:  Histochem J       Date:  2001-03

Review 3.  Immunobiology and privilege of neuronal retina and pigment epithelium transplants.

Authors:  J Wayne Streilein; Naili Ma; Hartmut Wenkel; Tat Fong Ng; Parisa Zamiri
Journal:  Vision Res       Date:  2002-02       Impact factor: 1.886

4.  Evidence that retinal pigment epithelium functions as an immune-privileged tissue.

Authors:  H Wenkel; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

5.  Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells.

Authors:  Li Song; Shujun Ge; Joel S Pachter
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

6.  Localization of caveolin-1 in photoreceptor synaptic ribbons.

Authors:  S Kachi; A Yamazaki; J Usukura
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

7.  VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.

Authors:  P Hofman; H G Blaauwgeers; M J Tolentino; A P Adamis; B J Nunes Cardozo; G F Vrensen; R O Schlingemann
Journal:  Curr Eye Res       Date:  2000-08       Impact factor: 2.424

8.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

Authors:  A M Joussen; T Murata; A Tsujikawa; B Kirchhof; S E Bursell; A P Adamis
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

9.  Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain).

Authors:  Freddy A Medina; Alex W Cohen; Cecilia J de Almeida; Fnu Nagajyothi; Vicki L Braunstein; Mauro Martins Teixeira; Herbert B Tanowitz; Michael P Lisanti
Journal:  Microbes Infect       Date:  2007-01-09       Impact factor: 2.700

10.  Association of a photoreceptor-specific tetraspanin protein, ROM-1, with triton X-100-resistant membrane rafts from rod outer segment disk membranes.

Authors:  Kathleen Boesze-Battaglia; Janice Dispoto; Mary Anne Kahoe
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

View more
  14 in total

1.  Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.

Authors:  Derek J Royer; Min Zheng; Christopher D Conrady; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

Review 2.  Caveolins and caveolae in ocular physiology and pathophysiology.

Authors:  Xiaowu Gu; Alaina M Reagan; Mark E McClellan; Michael H Elliott
Journal:  Prog Retin Eye Res       Date:  2016-09-21       Impact factor: 21.198

Review 3.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

4.  Bioinformatic Prioritization and Functional Annotation of GWAS-Based Candidate Genes for Primary Open-Angle Glaucoma.

Authors:  Nigus G Asefa; Zoha Kamali; Satyajit Pereira; Ahmad Vaez; Nomdo Jansonius; Arthur A Bergen; Harold Snieder
Journal:  Genes (Basel)       Date:  2022-06-13       Impact factor: 4.141

5.  Non-toxic retention of nanoceria in murine eyes.

Authors:  Xue Cai; Sudipta Seal; James F McGinnis
Journal:  Mol Vis       Date:  2016-10-12       Impact factor: 2.367

6.  MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.

Authors:  Inge Van Hove; Evy Lefevere; Lies De Groef; Jurgen Sergeys; Manuel Salinas-Navarro; Claude Libert; Roosmarijn Vandenbroucke; Lieve Moons
Journal:  Int J Mol Sci       Date:  2016-11-01       Impact factor: 5.923

7.  Caveolin-1 modulates intraocular pressure: implications for caveolae mechanoprotection in glaucoma.

Authors:  Michael H Elliott; Nicole E Ashpole; Xiaowu Gu; Leonie Herrnberger; Mark E McClellan; Gina L Griffith; Alaina M Reagan; Timothy M Boyce; Masaki Tanito; Ernst R Tamm; W Daniel Stamer
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

Review 8.  The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond.

Authors:  Andjela N Egger; Ali Rajabiestarabadi; Natalie M Williams; Sydney R Resnik; Joshua D Fox; Lulu L Wong; Ivan Jozic
Journal:  Exp Dermatol       Date:  2020-01-10       Impact factor: 3.960

Review 9.  Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief Review.

Authors:  Mojdeh Abbasi; Vivek Gupta; Nitin Chitranshi; Yuyi You; Yogita Dheer; Mehdi Mirzaei; Stuart L Graham
Journal:  Front Cell Neurosci       Date:  2018-03-27       Impact factor: 5.505

10.  Caveolin-1-Knockout Mouse as a Model of Inflammatory Diseases.

Authors:  Elena Codrici; Lucian Albulescu; Ionela Daniela Popescu; Simona Mihai; Ana-Maria Enciu; Radu Albulescu; Cristiana Tanase; Mihail E Hinescu
Journal:  J Immunol Res       Date:  2018-08-29       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.